HMGB1 and SQSTM1 are potential therapeutic targets for infection as well as sterile inflammation caused by tissue damage (Kang et al., 2014; Wang et al., 1999; Zhou et al., 2020; Zou et al., 2020). This evidence concerns the gene SQSTM1 and infection.